Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

HRT and breast cancer risk: a realistic perspective.

Stevenson JC, Hodis HN, Pickar JH, Lobo RA.

Climacteric. 2011 Dec;14(6):633-6. doi: 10.3109/13697137.2011.590618. Epub 2011 Aug 24.

PMID:
21864135
[PubMed - indexed for MEDLINE]
2.
3.

The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.

Kuhl H, Stevenson J.

Gynecol Endocrinol. 2006 Jun;22(6):303-17.

PMID:
16785155
[PubMed - indexed for MEDLINE]
4.

The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.

Lemay A.

J Obstet Gynaecol Can. 2002 Sep;24(9):711-5.

PMID:
12360366
[PubMed - indexed for MEDLINE]
5.

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.

de Lignières B, de Vathaire F, Fournier S, Urbinelli R, Allaert F, Le MG, Kuttenn F.

Climacteric. 2002 Dec;5(4):332-40.

PMID:
12626212
[PubMed - indexed for MEDLINE]
6.

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

Maturitas. 2006 Sep 20;55(2):103-15. Epub 2006 Jul 11.

PMID:
16815651
[PubMed - indexed for MEDLINE]
7.

Hormone replacement therapy in postmenopausal women.

Yasui T, Uemura H, Takikawa M, Irahara M.

J Med Invest. 2003 Aug;50(3-4):136-45. Review.

PMID:
13678382
[PubMed - indexed for MEDLINE]
8.

Perspectives on the Women's Health Initiative trial of hormone replacement therapy.

Grimes DA, Lobo RA.

Obstet Gynecol. 2002 Dec;100(6):1344-53. Review.

PMID:
12468183
[PubMed - indexed for MEDLINE]
9.

Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast.

Luo J, Cochrane BB, Wactawski-Wende J, Hunt JR, Ockene JK, Margolis KL.

Breast Cancer Res Treat. 2013 Feb;137(3):915-25. doi: 10.1007/s10549-012-2402-0. Epub 2013 Jan 12.

PMID:
23315265
[PubMed - indexed for MEDLINE]
10.
11.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.

Shapiro S, Farmer RD, Mueck AO, Seaman H, Stevenson JC.

J Fam Plann Reprod Health Care. 2011 Oct;37(4):225-30. doi: 10.1136/jfprhc-2011-0091. Epub 2011 Jun 2.

PMID:
21642263
[PubMed - indexed for MEDLINE]
12.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
[PubMed - indexed for MEDLINE]
13.

Incidences of breast cancer throughout long-term hormone replacement therapy.

Cortés-Prieto J, Juez-Martel P.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):180-9. Epub 2007 Mar 24.

PMID:
17467269
[PubMed - indexed for MEDLINE]
14.

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.

Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E.

Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9.

PMID:
10068383
[PubMed - indexed for MEDLINE]
15.

The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.

Hillman JJ, Zuckerman IH, Lee E.

J Womens Health (Larchmt). 2004 Nov;13(9):986-92.

PMID:
15665655
[PubMed - indexed for MEDLINE]
16.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

PMID:
15963666
[PubMed - indexed for MEDLINE]
17.

Postmenopausal hormone therapy: have HERS2 and WHI given us any new information?

Fylstra DL.

J S C Med Assoc. 2002 Dec;98(8):299-304.

PMID:
12532655
[PubMed - indexed for MEDLINE]
18.

Breast cancer risk in the WHI study: the problem of obesity.

Kuhl H.

Maturitas. 2005 May 16;51(1):83-97. Review.

PMID:
15883113
[PubMed - indexed for MEDLINE]
19.

Recent concerns surrounding HRT.

Armitage M, Nooney J, Evans S.

Clin Endocrinol (Oxf). 2003 Aug;59(2):145-55. Review.

PMID:
12864790
[PubMed - indexed for MEDLINE]
20.

Invited commentary: Postmenopausal unopposed estrogen and breast cancer risk in the Women's Health Initiative--before and beyond.

Linet MS.

Am J Epidemiol. 2008 Jun 15;167(12):1416-20. doi: 10.1093/aje/kwn089. Epub 2008 Apr 29.

PMID:
18448443
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk